Albert Zlotnik

51.4k citations
213 papers · 40.5k indexed · 14 hit papers · h-index 87

Albert Zlotnik

212 papers receiving 39.4k citations

Hit Papers

The Chemokine Superfamily Rev...912198620261999201210002.0k3.0k4.0k

Peers

Albert Zlotnik
Comparison fields: 5 of 161
  • Immunology 25.6k
  • Immunology and Allergy 4.0k
  • Oncology 16.9k
  • Dermatology 2.2k
  • Virology 718
Replace Osamu Yoshie with:
Osamu Yoshie Japan
Kenneth M. Murphy United States
Silvano Sozzani Italy
René de Waal Malefyt United States
Ko Okumura Japan
William E. Paul United States
Thomas F. Tedder United States
Ethan M. Shevach United States
Jeffrey A. Bluestone United States
Richard M. Locksley United States
Albert Zlotnik relative to Osamu Yoshie Japan Osamu Yoshie's profile →
Citations per field
00.5×1.5×2.1×
Osamu Yoshie · 1×
Citations per year

Countries citing papers authored by Albert Zlotnik

Since Specialization
Citations

This map shows the geographic impact of Albert Zlotnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Zlotnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Zlotnik more than expected).

Fields of papers citing papers by Albert Zlotnik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Zlotnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Zlotnik. The network helps show where Albert Zlotnik may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Albert Zlotnik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Albert Zlotnik Line = papers co-authored together Albert Zlotnik links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201910
2 201840
3 201872
4 201754
5 20161
6 201339
7 201130
8 200971
9 200820
10 2007189
11 2005182
12 200491
13 200248
14 2002279
15 200163
16 2000119
17 2000447
18 198812
19 198823
20 198887

About Albert Zlotnik

Albert Zlotnik is a scholar working on Immunology, Oncology and Immunology and Allergy, having authored 213 papers that have together received 40.5k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (84 papers), Immunotherapy and Immune Responses (64 papers), Immune Cell Function and Interaction (62 papers), Chemokine receptors and signaling (62 papers), Immune Response and Inflammation (23 papers), Glycosylation and Glycoproteins Research (19 papers), Cell Adhesion Molecules Research (15 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). The work is most often cited by research in Immunology (25.6k citations), Immunology and Allergy (4.0k citations) and Oncology (16.9k citations). Albert Zlotnik has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Osamu Yoshie, Dévora L. Rossi, Bernhard Homey, Anne O’Garra, Tim R. Mosmann, M Howard, David Fiorentino, Joseph A. Hedrick, Anja Müller and Hortensia Soto. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026